RxDoctor Payments DataLook up a doctor →

Eva Medvedova, MD

Hematology · Portland, ORNPI 1831242718

Payments from drug & device makers

$4,379,336in general payments, 2019–2025

Across 326 payments — averaging $13,434 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$2.6M
  • AbbVie$605K
  • Bristol Myers Squibb$508K
  • AstraZeneca$508K
  • Takeda Pharmaceuticals U.S.A., Inc.$119K
  • Amgen$84K
  • plus $153 from 1 others

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC201$2,555,308
AbbVie96$605,067
Bristol Myers Squibb7$508,308
AstraZeneca9$508,167
Takeda Pharmaceuticals U.S.A., Inc.9$118,763
Amgen2$83,570
Sanofi2$153

How this compares

$4,379,336 in reported general payments places this provider in the 95th percentile of 27 hematology providers in Oregon.

See all hematology providers in Oregon

Medicare billing

Part B allowed, 2024
$105,836
Medicare patients
236
Services billed
1,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →